COGT
Price
$5.33
Change
-$0.39 (-6.82%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
607.39M
39 days until earnings call
CYTOF
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Capitalization
264.5K
Ad is loading...

COGT vs CYTOF

Header iconCOGT vs CYTOF Comparison
Open Charts COGT vs CYTOFBanner chart's image
Cogent Biosciences
Price$5.33
Change-$0.39 (-6.82%)
Volume$35.05K
Capitalization607.39M
Altamira Therapeutics
Price$0.08
Change-$0.00 (-0.00%)
Volume$2.81K
Capitalization264.5K
COGT vs CYTOF Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. CYTOF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and CYTOF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (COGT: $5.34 vs. CYTOF: $0.07)
Brand notoriety: COGT and CYTOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 87% vs. CYTOF: 208%
Market capitalization -- COGT: $607.39M vs. CYTOF: $264.5K
COGT [@Biotechnology] is valued at $607.39M. CYTOF’s [@Biotechnology] market capitalization is $264.5K. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileCYTOF’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • CYTOF’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTOF is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while CYTOF’s TA Score has 2 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • CYTOF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, COGT is a better buy in the short-term than CYTOF.

Price Growth

COGT (@Biotechnology) experienced а -19.29% price change this week, while CYTOF (@Biotechnology) price change was -12.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($607M) has a higher market cap than CYTOF($264K). COGT (-26.667) and CYTOF (-27.602) have similar YTD gains .
COGTCYTOFCOGT / CYTOF
Capitalization607M264K229,924%
EBITDA-271.59MN/A-
Gain YTD-26.667-27.60297%
P/E RatioN/A0.04-
Revenue0N/A-
Total Cash287MN/A-
Total Debt17.5MN/A-
FUNDAMENTALS RATINGS
COGT vs CYTOF: Fundamental Ratings
COGT
CYTOF
OUTLOOK RATING
1..100
5422
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8894
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTOF's Valuation (8) in the Biotechnology industry is significantly better than the same rating for COGT (81) in the Miscellaneous industry. This means that CYTOF’s stock grew significantly faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (71) in the Miscellaneous industry is in the same range as CYTOF (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to CYTOF’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as CYTOF (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to CYTOF’s over the last 12 months.

COGT's Price Growth Rating (88) in the Miscellaneous industry is in the same range as CYTOF (94) in the Biotechnology industry. This means that COGT’s stock grew similarly to CYTOF’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as CYTOF (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to CYTOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTCYTOF
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 16 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 16 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 16 days ago
84%
Advances
ODDS (%)
Bullish Trend 23 days ago
84%
Bullish Trend 25 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 16 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 16 days ago
90%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNXT1.000.04
+4.17%
RenovoRx
LULU282.753.12
+1.12%
lululemon athletica
SRCE60.410.54
+0.90%
1st Source Corp
SUN59.130.35
+0.60%
Sunoco LP
PFIS44.610.01
+0.02%
Peoples Financial Services Corp

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.21%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
47%
Loosely correlated
+2.54%
ARWR - COGT
45%
Loosely correlated
+3.97%
IDYA - COGT
44%
Loosely correlated
+10.70%
CRNX - COGT
43%
Loosely correlated
+2.51%
More

CYTOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTOF has been loosely correlated with CMND. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTOF jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTOF
1D Price
Change %
CYTOF100%
-2.85%
CMND - CYTOF
56%
Loosely correlated
N/A
COGT - CYTOF
40%
Loosely correlated
-1.21%
SPHDF - CYTOF
35%
Loosely correlated
N/A
LOGC - CYTOF
32%
Poorly correlated
+3.40%
UBX - CYTOF
29%
Poorly correlated
+10.41%
More